Pramana and ARUP Laboratories Partner to Digitize Pathology Slides and Develop AI-Powered Hematopathology Algorithms for Deployment via Edge AI
CAMBRIDGE, Mass. & SALT LAKE CITY--(BUSINESS WIRE)--Mar 11, 2025--
Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology. The partnership combines ARUP's hematopathology expertise with Pramana's cutting-edge SpectralHT autonomous whole-slide imaging scanners to advance diagnostic precision and efficiency.
This press release features multimedia. View the full release here:
'Hematopathology involves highly complex and difficult-to-scan specimens, where traditional methods often fall short in delivering consistent and reproducible results,' said David Ng, MD, medical director of Hematologic Flow Cytometry and Applied Artificial Intelligence at ARUP Laboratories. 'By combining our deep clinical expertise with Pramana's large-scale digitization and AI-driven analysis, we have the ability to develop and clinically validate new AI algorithms that will improve diagnostic accuracy and workflow efficiency. Additionally, this collaboration lays the foundation for the broad distribution of these AI tools, ensuring greater accessibility and impact across the pathology community.'
The AI model development process will be led by ARUP, drawing on its expert hematopathologists and annotation tools to train, refine, and validate the algorithms using real-world clinical cases and pathology slides obtained for this purpose. These algorithms will be designed and tested to run efficiently on Pramana's SpectralHT scanners, demonstrating the viability of in-line edge computing for real-time AI-powered diagnostics. ARUP and Pramana will explore commercialization strategies to enable the seamless deployment and distribution of advanced diagnostic algorithms per regulatory standards, which will run efficiently on scanners and drive broader industry adoption in clinical diagnostics.
'This collaboration with ARUP Laboratories showcases how AI-driven pathology can redefine industry standards, making diagnostics more scalable, efficient, and interoperable,' said Prasanth Perugupalli, chief product officer at Pramana. 'By leveraging edge computing, we're accelerating the adoption of advanced diagnostic algorithms, including those for complex hematopathology cases. This approach enhances precision, removes scalability barriers, and seamlessly integrates AI-driven insights into lab workflows.'
Pramana's SpectralHT scanners feature in-line Edge AI computing, allowing real-time quality control and automated image processing. This streamlined workflow reduces the burden on lab personnel while ensuring high-quality data output. The SpectralHT scanners' volumetric imaging capabilities improve image quality and detail while enhancing scanning efficiency, even for the most challenging diagnostic slides, such as microbiology, hematopathology, parasitology, and cytology.
The ongoing partnership between ARUP Laboratories and Pramana underscores a broader commitment to digitization and AI-driven pathology advancements, signaling the potential for deeper integration and expanded initiatives, including clinical applications.
About Pramana, Inc.
Pramana, Inc., an AI-powered health tech company modernizing the pathology sector, enables seamless digital adoption by pathology labs and medical centers. Built upon extensive industry experience and patented technological innovation, Pramana is a gateway for pathologists and physicians to utilize AI-enabled decision support. The company is headquartered in Cambridge, Mass., and backed by Matrix Capital, a global leader in customized investment solutions, and NTTVC, a leading firm backing diverse founders within the technology spectrum. For more information, visit www.pramana.ai.
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah's Spencer Fox Eccles School of Medicine and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™. ARUP is ISO 15189 and CAP accredited. For more information, visit www.aruplab.com.
Pramana:
Andrea Sampson, Sampson PR Group
[email protected]:
Bonnie Stray
KEYWORD: UNITED STATES NORTH AMERICA UTAH MASSACHUSETTS
INDUSTRY KEYWORD: RESEARCH TECHNOLOGY MEDICAL DEVICES HEALTH TECHNOLOGY SOFTWARE BIOTECHNOLOGY HEALTH SCIENCE ONCOLOGY ARTIFICIAL INTELLIGENCE
SOURCE: Pramana
Copyright Business Wire 2025.
PUB: 03/11/2025 08:10 AM/DISC: 03/11/2025 08:09 AM
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Opinion: Science is Utah's quiet engine — don't stall it with cuts to important funding
Science quietly powers Utah's prosperity. From lifesaving diagnostics at ARUP Laboratories and cutting-edge biotech startups to clean energy research at Utah State and drought-resistant crops developed through university partnerships, science is behind much of what makes life in Utah better, longer and more secure. In 2024, the National Institutes of Health (NIH) awarded over $300 million to Utah institutions. That funding supported thousands of jobs, helped launch companies, and enabled groundbreaking research in everything from cancer treatments to Alzheimer's to rare disease therapies. Public health advances that benefit every Utahn — urban or rural — almost always begin through federally funded research. But now, that progress is in jeopardy. Proposed cuts and restrictions to NIH funding could have devastating effects on Utah's research institutions and economy. The plan to slash NIH's overall budget by nearly half, coupled with a proposal to reduce the indirect cost reimbursement to universities from around 50% to 15%, would mean far less money to cover the real costs of doing science. Basics like lab space, utilities, data storage and administrative support aren't luxuries — they're the infrastructure that makes research possible. For public universities like the University of Utah and Utah State, this isn't just a budget concern. It's a structural threat. Without adequate indirect cost support, universities would either have to drastically scale back research activity or shift the financial burden to students and state taxpayers. Both options would weaken Utah's competitive edge in science and technology. The consequences would ripple far beyond campus. Utah is known for its 'Industry' motto — a title that honors the resourcefulness and hard work that built our communities. Today, that industrious spirit thrives in our biotech labs, clean tech startups and health research centers. But industries can't thrive without innovation. Utah's life sciences sector depends on a steady pipeline of NIH-supported talent and discoveries emerging from research. Companies like Recursion, Myriad Genetics and BioFire Diagnostics thrive because of academic partnerships and access to skilled graduates. Pulling funding would slow innovation and shrink the talent pool. But it's not just about economics. It's about people. NIH funding supports clinical trials that help Utah families battling cancer. It funds suicide prevention programs in our schools, mental health outreach in rural counties, and pediatric care innovations at Primary Children's Hospital (PCH). It supports research for Native American communities and families dealing with chronic conditions like diabetes and asthma. Without that funding, many of these programs would disappear. I've seen the impact of public health investment firsthand. After I tested positive for latent tuberculosis as a student, I received free weekly treatment and health monitoring through the Utah County Health Department. It was science-backed care, delivered through a local system supported by federal resources. Without that treatment, I could have developed active tuberculosis — a threat not just to me but also to others. The system worked because it was built on scientific research and proactive policy. That kind of safety net doesn't happen without sustained funding. Furthermore, my nephew, Wesley, was cared for at PCH when he was just four months old. He was diagnosed with polyarteritis nodosa, a rare autoimmune disease that causes inflammation and damage to the heart. The NIH not only funds various programs at PCH but also was crucial to backing the science that led to properly diagnosing and saving Wesley. These cuts hurt the next generation. Graduate students and early career scientists — many of whom come from Utah — rely on federal research grants to get their start. If funding dries up, so do those opportunities. We risk losing promising young minds to other careers or other countries. This is not a partisan issue. Scientific progress should never be about politics. Every Utahn benefits from the medications they take, the clean water they drink, the safe food they eat and the medical care they receive. All of these are underpinned by science. Restricting it weakens our shared safety net and quality of life. Utah is built on hard work, innovation and foresight. Cutting science funding now would undermine the very foundation that allows us to adapt, compete and care for our communities. Science works for Utah — let's keep it that way.
Associated Press
29-05-2025
- Associated Press
Arup experts share trends shaping the future of rail at Asia Pacific Rail
HONG KONG SAR - Media OutReach Newswire - 29 May 2025 - Rail leaders of global sustainable development consultancy Arup from across the Asia Pacific region shared their insights into the future of rail at Asia Pacific Rail 2025, ranging from the role of transit-oriented development in funding rail infrastructure, the use of the latest green and smart technology in transit systems, station transformation, and customer journey planning. Arup experts gathered at Asia Pacific Rail 2025, exploring how to transform rail across the region. Held in Bangkok on 28-29 May 2025, the major rail event in the region was attended by 4,000 people and brought together more than 160 speakers and 200 exhibitors. As moderator of the keynote panel, TC Chew, Managing Director of APAC at Arup, discussed with leaders of key rail organisations in the region the crucial role of Transit-Oriented Development (TOD) in making public-private partnerships (PPPs) financially viable and sustainable, the challenges in implementing TOD as well as opportunities for future regional collaboration. 'Governments are under increasing pressure to look for innovative ways to fund rail projects. TOD could be part of the answer. If planned and designed carefully, TOD can help address challenges such as a growing population and demand for housing and employment, while promoting efficient transport options needed for a long-term sustainable future,' said TC. James Musgrave, APAC Rail Business Leader at Arup, said, 'From the Kowloon Station development in Hong Kong to the Sydney Metro Martin Place integrated station development in Australia, Arup provided strategic planning, design and engineering expertise to maximise the value of investment in transit infrastructure and the positive impact on the community it serves. When we create an impactful TOD, we don't just change how a city moves, we redefine how people live.' Three leaders from Arup also spoke at Asia Pacific 2025 on major topics in railway development: In addition, Arup sponsored the British Embassy Reception, where Arup's clients and partners connected with rail leaders to exchange ideas and share insights. With over 6,400 people in 28 offices across Asia Pacific and direct access to a larger global network, Arup is committed to supporting clients to deliver transformative railways that enhance lives and connectivity across cities and nations. Hashtag: #Rail #TransitOrientedDevelopment #Arup Wechat: Arup奥雅纳 The issuer is solely responsible for the content of this announcement. Arup Arup is a global built environment consultancy with advisory and technical expertise across more than 150 disciplines. We create safe, resilient, and regenerative places, bringing a Total Design approach to our work for our clients.
Yahoo
23-05-2025
- Yahoo
City centre regeneration plans take step forward
Plans to double the size of Bradford city centre, creating an area described as "one of the biggest regeneration sites in the UK", have taken a major step forward. At a forum in Leeds on Wednesday, Bradford Council announced that global consultancy firm Arup had been commissioned to create the "master plan" for the city's proposed Southern Gateway. The scheme involves redeveloping the area between Leeds Road and Manchester Road for new housing, businesses, shops and infrastructure, including tram stations and a possible new "through" railway station for the city. A council spokesman said: "This is a transformational opportunity, bringing with it huge economic and social benefits." The plans for the Southern Gateway were originally announced at this year's UK Real Estate Investment and Infrastructure Forum, according to the Local Democracy Reporting Service. The master plan, which is expected to be created over 12 months, would look at the requirements of the development, taking into account the city's heritage and need for "landscape enhancements". The project includes plans for £4.5bn of transport upgrades, including trams and a new Bradford railway station. Councillor Susan Hinchcliffe, leader of Bradford Council, said: "This once-in-a-lifetime opportunity will drive growth for the district, strengthen supply chains, boost productivity and attract private investment, ensuring Bradford thrives in a competitive landscape." The master plan would create "a tangible, detailed proposal from street level right the way up to how the new district will work within the city as a whole", she said. "It will be key in terms of attracting future investment." Hinchliffe also highlighted that Bradford was the largest city without direct access to the major north-south railway lines. "A new 'through' rail station in the Southern Gateway is critical to delivering the social and economic benefits of faster travel between regional economic hubs and also to London," she said. "It will unlock opportunities for young people, with faster, easier access to jobs, apprenticeships, and universities." Niall Bourkem, associate director at Arup, said the master plan "reflects the city of Bradford's vision and commitment to creating an inclusive, sustainable, and resilient future". "With the future rail station and the West Yorkshire Combined Authority's mass transit plans providing momentum, the master plan will set out a clear path for new homes, jobs, cultural opportunities and improved connectivity," he explained. Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North. Bradford Council Preferred route of new tram line revealed Station work 'to create world-class gateway' to city
